The viral vector and plasmid DNA manufacturing market offers growth opportunities in gene therapies, contract manufacturing, and emerging markets like Asia-Pacific. Key trends include rising demand ...

The global gene therapy market size is projected to expand significantly, with an estimated value of USD 19.3 billion by 2034 ...

The viral vector specialist SIRION Biotech has announced the signing of a preferred partnership agreement with Heidelberg University Hospital ...

New expedited service line designed for biotechs with timeline constraints, launched in response to client demandCan accelerate timeline to GMP ...

Researchers developed a gorilla adenovirus platform with inherent tumor selectivity, lung tropism, and large-gene capacity.

* Viral Vector Analysis Services Creative Biolabs provides a full range of viral vector analytical solutions with advanced equipment and technology, including AAV vector analysis, lentiviral vector ...

Oxford, UK – 18 March 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces that it has entered into a licensing and option agreement with Viral Vector ...

LumaCyte today announced that its analytical approach has been included in the newly published International Organization for Standardization (ISO) global standard for gene delivery systems, ISO 16921 ...

Polyethylenimine (PEI)-assisted transfection is a mainstay in upstream processing (USP) for viral vector manufacturing. But recent developments are shifting it from a ...

Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing and quality control services. SHIRLEY, NY, UNITED ...